EI
CERE

Ellevest Inc’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Ellevest Inc’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-81
Closed -$1.98K – 1746
2023
Q1 		$1.98K Sell
81
-3
-4% -$88 ﹤0.01% 1446
2022
Q4 		$2.65K Buy
+84
New +$2.37K ﹤0.01% 1333
2022
Q3 		– Sell
-115
Closed -$3K – 1918
2022
Q2 		$3K Buy
115
+75
+188% +$2.13K ﹤0.01% 1127
2022
Q1 		$1K Hold
40
– – ﹤0.01% 1364
2021
Q4 		$1K Buy
+40
New +$1.41K ﹤0.01% 1355

Other funds holding CERE

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Ellevest Inc's CERE Position: Q2 2023 in Review

Ellevest Inc sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q2 2023, closing a stake of 81 shares — an estimated $1.98K sold.

Ellevest Inc first reported a position in CERE in Q4 2021 and held it in 5 quarters. The position peaked at $3K in Q2 2022. 125 funds tracked by Wall St. Rank hold CERE as of Q2 2023.

  • Ellevest Inc reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 81 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q2 2023, an estimated $1.98K.
  • Ellevest Inc first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Ellevest Inc's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $3K in Q2 2022.
  • 125 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.